Pradaxa Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Financial assistance Patient education People also ask

Pradaxa(dabigatran etexilate)

Pradaxa 75 MG Oral Capsule

Dosage & Administration

* Non-valvular Atrial Fibrillation in Adult Patients:
* For patients with CrCl > 30 mL/min: 150 mg orally, twice daily
* For patients with CrCl 15-30 mL/min: 75 mg orally, twice daily

* Treatment of DVT and PE in Adult Patients:
* For patients with CrCl > 30 mL/min: 150 mg orally, twice daily after 5-10 days of parenteral anticoagulation

* Reduction in the Risk of Recurrence of DVT and PE in Adult Patients:
* For patients with CrCl > 30 mL/min: 150 mg orally, twice daily after previous treatment

* Prophylaxis of DVT and PE Following Hip Replacement Surgery in Adult Patients:
* For patients with CrCl > 30 mL/min: 110 mg orally first day, then 220 mg once daily

* Treatment of Pediatric VTE:
* For pediatric patients: weight-based dosage, twice daily after at least 5 days of parenteral anticoagulant

* Reduction in the Risk of Recurrence of Pediatric VTE:
* For pediatric patients: weight-based dosage, twice daily after previous treatment

* Pradaxa Capsules are NOT substitutable on a milligram-to-milligram basis with other dabigatran etexilate dosage forms
* Review recommendations for converting to or from other oral or parenteral anticoagulants
* Temporarily discontinue PRADAXA before invasive or surgical procedures when possible, then restart promptly

drug label

Pradaxa Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

prior authorization

Pradaxa Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

financial assistance

Pradaxa Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form